Top Banner
MCQ ON CARDIOLOGY I 1
84

Mcq on Cardiology i (1)

Oct 22, 2014

Download

Documents

Harsh Oak
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Mcq on Cardiology i (1)

MCQ ON CARDIOLOGY I

1

Page 2: Mcq on Cardiology i (1)

PAH

2

Page 3: Mcq on Cardiology i (1)

Which of these may be used for management of pulmonary arterial hypertension?Calcium channel blockersProstacyclinsBosentan

All of the above---------------

3

Page 4: Mcq on Cardiology i (1)

Use of sildenafil is contraindicated with:Amyl nitrateIsosorbide dinitrateNitroglycerine

All of the above------------

Which of these prostacyclin is active when administered orally?Iloprost--------------EpoprostenolSodium BeraprostTreprostinil

4

Page 5: Mcq on Cardiology i (1)

   Safe antihypertensive drugs in pregnancy include:

 i.) Furosemideii.) Hydralazineiii.) Methyldopaiv.) Diazoxidev.) Hydrochlorothiazide 

5

Page 6: Mcq on Cardiology i (1)

6

Page 7: Mcq on Cardiology i (1)

7

Page 8: Mcq on Cardiology i (1)

8

Page 9: Mcq on Cardiology i (1)

RJ is a 47-year-old man with a past medical history of sickle cell disease, severely depressed right ventricular systolic function, who has been newly diagnosed with primary pulmonary hypertension on right heart catheterization. He has a positive response to adenosine vasodilator challenge during catheterization. His pulmonary artery systolic pressure is 60 mm Hg. He is in functional class III. His current medications include: warfarin 10 mg daily, metoprolol 25 mg twice daily, furosemide 20 mg twice daily, hydroxyurea 500 mg daily, and risperidone 4 mg at bedtime. His heart rate is 67 beats/minute and blood pressure is 118/57 mm Hg. Which medication should RJ be initiated on to prevent mortality and progression of his pulmonary hypertension?

(A) epoprostenol 2 ng/kg/minute(B) diltiazem 240 mg daily(C) bosentan 62.5 mg PO twice daily(D) inhaled iloprost 2.5 mcg x1, then 5 mcg/inhalation through nebulizer 6–9 times daily

9

Page 10: Mcq on Cardiology i (1)

In patients with an acute vasodilator response to challenge during right heart catheterization, they should receive a calcium channel blocker to prevent mortality. In this patient, metoprolol may require dosage reduction or substitution with an ACE inhibitor to allow adequate blood pressure and heart rate for diltiazem therapy. Alternatively, amlodipine could be utilized if the patient has to remain on metoprolol but his heart rate cannot tolerate both diltiazem and metoprolol together. All alternative vasodilators should be reserved for patients who do not respond adequately to a vasodilator challenge during catheterization or who are failing calcium channel blocker therapy. Epoprostenol should be reserved for those in functional class IV to prevent mortality and also should be reserved as an alternative to patients who do not respond to or are failing calcium channel blockers.

10

Page 11: Mcq on Cardiology i (1)

11

Page 12: Mcq on Cardiology i (1)

12

Page 13: Mcq on Cardiology i (1)

13

Page 14: Mcq on Cardiology i (1)

Blood PressureBlood Pressure in a 28 y.o. of 200s+/130s+ in a 28 y.o. of 200s+/130s+ mm/Hgmm/Hg..

He has acute on chronic renal failure He has acute on chronic renal failure (BUN/Creatinine 46/4.7 from 30/2.8 mg/dl) (BUN/Creatinine 46/4.7 from 30/2.8 mg/dl)

and and schistocytesschistocytes..

If the hypertensive emergency was If the hypertensive emergency was discovered earlier which agent below would discovered earlier which agent below would

have been the most appropriate therapyhave been the most appropriate therapy??A.) hydralazine parenterallyA.) hydralazine parenterallyB.) clonidine loadingB.) clonidine loadingC.) fenoldopamC.) fenoldopamD.) nitroprussideD.) nitroprussideE.) nitroglycerinE.) nitroglycerin

14

Page 15: Mcq on Cardiology i (1)

15

Page 16: Mcq on Cardiology i (1)

There are several antihypertensive agents available including esmolol, nicardipine, labetalol, and fenoldopam. While sodium nitroprusside is a rapid-acting and potent antihypertensive agent, it may be associated with significant toxicity and should therefore be used in select circumstances at a dose not to exceed 2 μg/kg/min. The appropriate therapeutic approach of each patient will depend on the clinical presentation of the patient. Agents such as nifedipine and hydralazine should be abandoned because these agents are associated with significant toxicities and/or side effect profile.

16

Page 17: Mcq on Cardiology i (1)

The Arrhythmias

17

Page 18: Mcq on Cardiology i (1)

18

Page 19: Mcq on Cardiology i (1)

19

Page 20: Mcq on Cardiology i (1)

20

Page 21: Mcq on Cardiology i (1)

Dr. S's grandfather is a 81 YO male who is admitted with ECG showing wide comples tachycardia. PMH is significant for MI 2 months ago and valvular heart disese. Which drug(s) would be contraindicated for him?

a). sotalolb). Propafenonec). disopyramided). amiodaronee). B and C

B and CPropafenone and disopyramide are class Ic and Ia drugs, respectively and are contraindicated in heart disease.

21

Page 22: Mcq on Cardiology i (1)

22

Page 23: Mcq on Cardiology i (1)

23

Page 24: Mcq on Cardiology i (1)

24

Page 25: Mcq on Cardiology i (1)

25

Page 26: Mcq on Cardiology i (1)

26

Page 27: Mcq on Cardiology i (1)

27

Page 28: Mcq on Cardiology i (1)

28

Page 29: Mcq on Cardiology i (1)

29

Page 30: Mcq on Cardiology i (1)

30

Page 31: Mcq on Cardiology i (1)

31

Page 32: Mcq on Cardiology i (1)

32

Page 33: Mcq on Cardiology i (1)

33

Page 34: Mcq on Cardiology i (1)

34

Page 35: Mcq on Cardiology i (1)

35

Page 36: Mcq on Cardiology i (1)

36

Page 37: Mcq on Cardiology i (1)

37

Page 38: Mcq on Cardiology i (1)

38

Page 39: Mcq on Cardiology i (1)

39

Page 40: Mcq on Cardiology i (1)

40

Page 41: Mcq on Cardiology i (1)

41

Page 42: Mcq on Cardiology i (1)

42

Page 43: Mcq on Cardiology i (1)

43

Page 44: Mcq on Cardiology i (1)

44

Page 45: Mcq on Cardiology i (1)

45

Page 46: Mcq on Cardiology i (1)

46

Page 47: Mcq on Cardiology i (1)

47

Page 48: Mcq on Cardiology i (1)

48

Page 49: Mcq on Cardiology i (1)

49

Page 50: Mcq on Cardiology i (1)

50

Page 51: Mcq on Cardiology i (1)

51

Page 52: Mcq on Cardiology i (1)

52

Page 53: Mcq on Cardiology i (1)

53

Page 54: Mcq on Cardiology i (1)

54

Page 55: Mcq on Cardiology i (1)

55

Page 56: Mcq on Cardiology i (1)

56

Page 57: Mcq on Cardiology i (1)

57

Page 58: Mcq on Cardiology i (1)

58

Page 59: Mcq on Cardiology i (1)

59

Page 60: Mcq on Cardiology i (1)

60

Page 61: Mcq on Cardiology i (1)

61

Page 62: Mcq on Cardiology i (1)

62

Page 63: Mcq on Cardiology i (1)

63

Page 64: Mcq on Cardiology i (1)

64

Page 65: Mcq on Cardiology i (1)

65

Page 66: Mcq on Cardiology i (1)

66

Page 67: Mcq on Cardiology i (1)

ADHF

67

Page 68: Mcq on Cardiology i (1)

68

Page 69: Mcq on Cardiology i (1)

69

Page 70: Mcq on Cardiology i (1)

70

Page 71: Mcq on Cardiology i (1)

71

Page 72: Mcq on Cardiology i (1)

72

Page 73: Mcq on Cardiology i (1)

73

Page 74: Mcq on Cardiology i (1)

74

Page 75: Mcq on Cardiology i (1)

75

Page 76: Mcq on Cardiology i (1)

76

Page 77: Mcq on Cardiology i (1)

77

Page 78: Mcq on Cardiology i (1)

78

Page 79: Mcq on Cardiology i (1)

79

Page 80: Mcq on Cardiology i (1)

80

Page 81: Mcq on Cardiology i (1)

81

Page 82: Mcq on Cardiology i (1)

82

Page 83: Mcq on Cardiology i (1)

83

Page 84: Mcq on Cardiology i (1)

GOOD LUCK

84